Skip to content
Home/Companies/MedTech/Clinomic
Clinomic

Clinomic

MedTech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Clinomic?

Clinomic is a German MedTech company, currently owned by DeepTech & Climate Fonds since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
DeepTech & Climate Fonds
Investor
DeepTech & Climate Fonds
DeepTech & Climate Fonds · 2022 · Evergreen

Key facts

HQGermany
SectorMedTech
StatusActive
Websitewww.clinomic.ai

More from DeepTech & Climate Fonds

Other portfolio companies in the same fund.

Stenon
Stenon
Active
SoftwareGermany· 2026
Synera
Synera
Active
SaaSGermany· 2026
UniverCell
UniverCell
Active
ClimateTechGermany· 2026
Genomines
Genomines
Active
IndustrialsFrance· 2025
Hypatos
Active
SoftwareGermany· 2025
node.energy
Active
ClimateTechGermany· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Clinomic?

Clinomic is currently owned by DeepTech & Climate Fonds, through DeepTech & Climate Fonds, since 2025.

When did DeepTech & Climate Fonds acquire Clinomic?

DeepTech & Climate Fonds acquired Clinomic in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue